Who is sponsoring NCT03836898?

NCT03836898 is sponsored by Gemini Eye Clinic.

What drugs are being tested in NCT03836898?

Interventions in NCT03836898: Presbyopic posterior chamber phakic intraocular lens IPCL.

What condition does NCT03836898 study?

NCT03836898 studies Presbyopia, Myopia.

Is NCT03836898 still recruiting?

NCT03836898 is currently completed. Last updated 10 May 2019.

Last reviewed 2019-05-10 · How we verify

NCT03836898

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Presbyopic Phakic Intraocular Lens for Myopia Correction

Completed NA Last updated 10 May 2019

What this trial tests

NA trial testing Presbyopic posterior chamber phakic intraocular lens IPCL in Presbyopia in 10 participants. Completed in 31 December 2018.

Timeline

1 January 2016

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	Gemini Eye Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	1 January 2016
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across Czechia

Drugs / interventions tested

Presbyopic posterior chamber phakic intraocular lens IPCL

Conditions studied

Presbyopia — all drugs for Presbyopia →
Myopia — all drugs for Myopia →

Sponsor

Gemini Eye Clinic

Who can join

Adults 38 to 50, any sex, with Presbyopia or Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective single-center study of implantations of the presbyopic version of phakic intraocular lens IPCL (EyeolUK, United Kingdom).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Presbyopia

Currently open trials in the same condition.

NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting

Other Gemini Eye Clinic trials

Trials by the same sponsor.

NCT07133737 — 5 Year Follow up of SMILE® Procedure for the Correction of Hyperopia · enrolling by invitation
NCT04523558 — Evaluation of the Extended Depth of Focus After Bilateral Implantation of Hydrophobic IOLs · NA · completed
NCT07173907 — Epi-on CuRV and Epi-off aCXL Protocols in the Management of Keratoconus · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03836898 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gemini Eye Clinic
Last refreshed: 10 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03836898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing